Vansteenkiste, Johan <br/><br/>
Darbepoetin alfa for chemotherapy-induced anemia: evolution to extended dosing intervals.  [electronic resource] 

 -  Expert review of anticancer therapy  Oct 2007 
 - 1347-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-8328 
<br/><br/><label>Standard No.: </label>10.1586/14737140.7.10.1347  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anemia--chemically induced<br/>Antineoplastic Agents--adverse effects<br/>Blood Transfusion<br/>Clinical Trials as Topic--statistics & numerical data<br/>Combined Modality Therapy<br/>Darbepoetin alfa<br/>Drug Administration Schedule<br/>Drug Approval<br/>Erythropoietin--administration & dosage<br/>Humans<br/>Injections, Intravenous<br/>Injections, Subcutaneous<br/>Iron-Dextran Complex--administration & dosage<br/>Neoplasms--blood<br/>Quality of Life<br/>Randomized Controlled Trials as Topic--statistics & numerical data<br/>Thromboembolism--chemically induced